Five Star Equities Provides Stock Research on Discovery Laboratories and Cardium Therapeutics
Continue ReadingCategory: Picture Gallery
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Ariad Pharmaceuticals and AVEO Pharmaceuticals
Continue Reading
Gold Futures Surge to 1 Month Highs on Optimism That the Upcoming “Fiscal Cliff” Can Be Avoided
The Paragon Report Provides Stock Research on Newmont Mining and Goldcorp
Continue Reading
U.S. Foreign Oil Imports Projected to Decline by More Than 50% Within the Next Decade
The Paragon Report Provides Stock Research on Forest Oil and Petroquest Energy
Continue Reading
FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011
Five Star Equities Provides Stock Research on CytRx and ZIOPHARM Oncology
Continue Reading
Spackman Equities Group Reports Third Quarter 2012 Results
TORONTO, ONTARIO -- (Marketwire) -- 11/26/12 -- Spackman Equities Group Inc. ("SEGI") (TSX VENTURE: SQG) announces…
Continue Reading
Interactive Data Enhances Feed Handler to Help Financial Institutions Improve Performance and Reduce Costs
Highly Optimized Feed Handler Enables Seamless Integration of Consolidated Feed Within Customers- Existing Market Data Platforms
Continue Reading